Showing results (131-140 of 792) with videos related to
Sort By:
Pageof 80
Cancer|July 13, 2016
Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participationAjay K Nooka, Madhusmita Behera, Sagar Lonial, et al.Cancer Research|May 19, 2007
The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cellsXiangguo Liu, Ping Yue, Shuzhen Chen, et al.Cancer Research|May 19, 2007
The farnesyltransferase inhibitor R115777 up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer cellsYuanzheng Qiu, Xiangguo Liu, Wei Zou, et al.The Journal of Biological Chemistry|March 26, 2010
Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradationChunyang Li, Shuzhen Chen, Ping Yue, et al.Annals of Hematology|April 17, 2024
Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelinesCharalampos Charalampous, Darshi Shah, Shaji Kumar, et al.Mayo Clinic Proceedings|February 13, 2002
Acquired von Willebrand diseaseShaji Kumar, Rajiv K Pruthi, William L NicholsPET Clinics|May 16, 2019
Fludeoxyglucose F 18 PET/Computed Tomography Evaluation of Therapeutic Response in Multiple MyelomaShaji Kumar, Katrina N Glazebrook, Stephen M BroskiOncology and Therapy|April 4, 2022
Current Role of Allogeneic Stem Cell Transplantation in Multiple MyelomaJean-Sébastien Claveau, Francis K Buadi, Shaji KumarHematology/Oncology Clinics of North America|December 29, 2023
Smoldering Multiple Myeloma: Observation Versus Control Versus CureS Vincent Rajkumar, P Leif Bergsagel, Shaji KumarAmerican Journal of Hematology|April 1, 2003
Acquired von Willebrand's syndrome: a single institution experienceShaji Kumar, Rajiv K Pruthi, William L NicholsPageof 80